Alcon

Alcon FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Alcon (ALC.SW) as of Sep 25, 2026 is 176.33 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 138.21 % — a change of 27.58% (higher).

FCF Conversion

176.33 %

YoY

27.58%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Alcon is 2026 176.33 % . FCF Conversion Rate (FCF/EBITDA) of Alcon was 2025 138.21 % . It decreases by 27.58% higher compared to the previous year.

The Alcon FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2018
-135.87 USD
Jan 1, 2019
-37.20 USD
Jan 1, 2020
-48.21 USD
Jan 1, 2021
43.88 USD
Jan 1, 2022
140.90 USD
Jan 1, 2023
55.13 USD
Jan 1, 2024
138.21 USD
Jan 1, 2025
176.33 USD
The Alcon FCF Conversion history
YEARFCF ConversionYoY
176.33 %+27.58%
138.21 %+150.69%
55.13 %-60.87%
140.90 %+221.07%
43.88 %-191.02%
-48.21 %+29.62%
-37.20 %-72.63%
-135.87 %-148.18%
282.03 %-164.88%
-434.71 %-244.90%
300.00 %—
Access this data via the Eulerpool API

Alcon Stock analysis

What does Alcon do? Alcon AG is a leading company in ophthalmology with more than 70 years of experience in this industry. The company was founded in 1945 by Robert Alexander and William Conner and has its headquarters in Geneva, Switzerland. Alcon AG has been part of the Novartis Group since 2019 and is a leader in the production of ophthalmic products. The business model of Alcon AG is based on the manufacturing and sale of ophthalmic products. The company offers medical products such as contact lenses, surgical instruments, eye drops, and intraocular lenses. Alcon AG specializes in the development of products that can be used for various eye diseases. The company provides a wide range of products that can be used by ophthalmologists and opticians. The various divisions of Alcon AG include eye care products, surgical products, and diagnostic products. Eye care products, such as contact lenses, offer consumers a safe and easy way to correct their vision. Surgical products include a wide range of instruments used in eye surgeries. Diagnostic products help identify eye diseases and support treatment. Alcon AG specializes in the development of products for the treatment of eye diseases. These include conditions such as cataracts, glaucoma, and age-related macular degeneration. The company offers various products that can be used for these conditions, such as eye drops to reduce elevated eye pressure in glaucoma. It has also developed a wide range of products for refractive correction, allowing people to improve their vision. Alcon AG works closely with leading ophthalmologists and opticians to optimize its product development. This close collaboration ensures that Alcon AG's products meet the needs of patients and provide them with high safety and effectiveness. With its innovative products and technologies, Alcon AG aims to improve the quality of life for patients and provide them with optimal care and treatment. Overall, Alcon AG is a leading company in ophthalmology, offering its customers a wide range of innovative and high-quality products. From diagnosis to care to surgical interventions, Alcon AG's product range covers all areas of ophthalmology. The company is known for its research and development and is constantly working towards advancing ophthalmology. Through its continuous innovation and customer orientation, Alcon AG has established a strong position in the healthcare industry and will continue to introduce new products and technologies in the future. Alcon is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Alcon stock

FCF Conversion Rate (FCF/EBITDA) of Alcon is 176.33 % in 2026.

FCF Conversion Rate (FCF/EBITDA) of Alcon changed from 138.21 % to 176.33 %, representing a 27.58% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Alcon since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Alcon with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

Cash Flow — Alcon

All Key Metrics — Alcon